Efficacy of anlotinib in advanced soft tissue sarcoma by age, gender, and ECOG performance status.

被引：0
|
作者：
Fang, Zhiwei
Yao, Yang
Cai, Jianqiang
Chi, Yihebali
Wang, Shusen
Huang, Gang
Cai, Qiqing
Shang, Guanning
Wang, Guowen
Qu, Guofan
Wu, Qiong
Jiang, Yu
Song, Jianmin
Chen, Jing
Cai, Zhengdong
Zhu, Xia
Bai, Chunmei
Lu, Yongkui
Yu, Zhihua
Shen, Jingnan
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China
[3] Canc Hosp, Dept Abdominal Surg, CAMS, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[6] Hunan Canc Hosp, Changsha, Peoples R China
[7] Henan Canc Hosp, Zhengzhou, Peoples R China
[8] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[9] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[10] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[11] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[12] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[13] Gansu Prov Canc Hosp, Lanzhou, Peoples R China
[14] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[15] Shanghai Jiao Tong Univ, Peoples Hosp 1, Shanghai, Peoples R China
[16] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[17] Peking Union Med Coll Hosp, Beijing, Peoples R China
[18] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China
[19] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China
[20] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23562
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification
    Yao, Y.
    Chi, Y.
    Fang, Z.
    Wang, S.
    Huang, G.
    Cai, Q.
    Shang, G.
    Wang, G.
    Qu, G.
    Wu, Q.
    Jiang, Y.
    Song, J.
    Chen, J.
    Zhu, X.
    Cai, Z.
    Bai, C.
    Lu, Y.
    Yu, Z.
    Shen, J.
    Cai, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
    Ni, Ying
    Dong, Yabing
    Jiang, Aijun
    Zhang, Qun
    Wang, Zhantong
    Liang, Hui
    Zhang, Wei
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [3] Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
    Wang, Hai-ying
    Chu, Jun-feng
    Zhang, Peng
    Wang, Jia-qiang
    Yan, Zheng
    Yao, Shu-na
    Yao, Zhi-hua
    Liu, Yan-yan
    ONCOTARGETS AND THERAPY, 2020, 13 : 1561 - 1568
  • [4] Evaluation of hypertension and hand-foot syndrome as markers of anlotinib efficacy in advanced soft tissue sarcoma
    Fang, Z.
    Chi, Y.
    Yao, Y.
    Wang, S.
    Huang, G.
    Cai, Q.
    Shang, G.
    Wang, G.
    Qu, G.
    Wu, Q.
    Jiang, Y.
    Song, J.
    Chen, J.
    Zhu, X.
    Cai, Z.
    Bai, C.
    Lu, Y.
    Yu, Z.
    Shen, J.
    Cai, J.
    ANNALS OF ONCOLOGY, 2018, 29 : 587 - 587
  • [5] Efficacy of Anlotinib combined with S-1 as the second-line treatment for advanced soft tissue sarcoma
    Tie, Xiao-Jing
    Yang, Chen-Guang
    Gao, Yao-Hong
    Liu, Pei-Jie
    ASIAN JOURNAL OF SURGERY, 2023, 46 (02) : 1050 - 1051
  • [6] Anlotinib rechallenge combined with immune checkpoint inhibitor for advanced soft tissue sarcoma after the failure of anlotinib.
    Fu, Yang
    Jiang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Efficacy and safety of anlotinib combined with anthracycline and ifosfamide followed by anlotinib maintenance in advanced soft tissue sarcoma: A single-arm, phase 2 trial
    Liu, Zengjun
    Liu, Mengyao
    Xu, Jing
    Hu, Wenyu
    Zhu, Dongyuan
    Tao, Rongjie
    Xu, Ni
    Zhang, Hui
    Li, Minghuan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Efficacy and safety of anlotinib combined with liposomal doxorubicin in first-line treatment of advanced soft-tissue sarcoma.
    Sun, Xin
    Guo, Wei
    Zhang, Ranxin
    Xie, Lu
    Xu, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma
    Tian, Zhichao
    Liu, Huimin
    Zhang, Fan
    Li, Liangyu
    Du, Xinhui
    Li, Chao
    Yan, Jinpo
    Wang, Jiaqiang
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1559 - 1569
  • [10] The effect of treatment line on the efficacy of anlotinib hydrochloride in advanced alveolar soft part sarcoma patients
    Fang, Z.
    Yao, Y.
    Cai, J.
    Chi, Y.
    Wang, S.
    Huang, G.
    Cai, Q.
    Shang, G.
    Wang, G.
    Qu, G.
    Wu, Q.
    Jiang, Y.
    Song, J.
    Chen, J.
    Cai, Z.
    Zhu, X.
    Bai, C.
    Lu, Y.
    Yu, Z.
    Shen, J.
    ANNALS OF ONCOLOGY, 2019, 30
12345